Product Code: ETC12125074 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Japan continued to see significant import shipments of erlotinib hydrochloride tablets, with top exporting countries being the USA, Germany, Ireland, Switzerland, and Sweden. Despite the presence of multiple exporters, market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low. The compound annual growth rate (CAGR) from 2020 to 2024 was -3.23%, indicating a slight decline in demand over the period. Furthermore, the growth rate from 2023 to 2024 was -2.99%, suggesting a continued downward trend in import volumes for this medication in Japan.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Exeter Erlotinib Hydrochloride Tablet Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Exeter Erlotinib Hydrochloride Tablet Market - Industry Life Cycle |
3.4 Japan Exeter Erlotinib Hydrochloride Tablet Market - Porter's Five Forces |
3.5 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.8 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Exeter Erlotinib Hydrochloride Tablet Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Japan |
4.2.2 Growing adoption of targeted therapy for cancer treatment |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for pharmaceutical products in Japan |
4.3.2 High cost associated with erlotinib hydrochloride tablets |
4.3.3 Competition from alternative treatment options for lung cancer |
5 Japan Exeter Erlotinib Hydrochloride Tablet Market Trends |
6 Japan Exeter Erlotinib Hydrochloride Tablet Market, By Types |
6.1 Japan Exeter Erlotinib Hydrochloride Tablet Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib Tablets, 2021 - 2031F |
6.1.4 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 100mg Tablets, 2021 - 2031F |
6.1.5 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 150mg Tablets, 2021 - 2031F |
6.1.6 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 25mg Tablets, 2021 - 2031F |
6.2 Japan Exeter Erlotinib Hydrochloride Tablet Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.3 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 100mg Tablets, 2021 - 2031F |
6.2.4 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 150mg Tablets, 2021 - 2031F |
6.2.5 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 25mg Tablets, 2021 - 2031F |
6.3 Japan Exeter Erlotinib Hydrochloride Tablet Market, By Therapeutic Class |
6.3.1 Overview and Analysis |
6.3.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By EGFR Inhibitors, 2021 - 2031F |
6.3.3 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Drugs, 2021 - 2031F |
6.3.4 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Anticancer Medications, 2021 - 2031F |
6.3.5 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Alternatives, 2021 - 2031F |
6.4 Japan Exeter Erlotinib Hydrochloride Tablet Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.4.3 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021 - 2031F |
6.4.4 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Pancreatic Cancer Patients, 2021 - 2031F |
6.4.5 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Patients with Limited Treatment Options, 2021 - 2031F |
7 Japan Exeter Erlotinib Hydrochloride Tablet Market Import-Export Trade Statistics |
7.1 Japan Exeter Erlotinib Hydrochloride Tablet Market Export to Major Countries |
7.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Imports from Major Countries |
8 Japan Exeter Erlotinib Hydrochloride Tablet Market Key Performance Indicators |
8.1 Patient adherence rate to erlotinib hydrochloride treatment regimen |
8.2 Number of clinical trials exploring the efficacy of erlotinib hydrochloride tablets |
8.3 Rate of adoption of erlotinib hydrochloride tablets by healthcare providers |
9 Japan Exeter Erlotinib Hydrochloride Tablet Market - Opportunity Assessment |
9.1 Japan Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Japan Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.4 Japan Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Exeter Erlotinib Hydrochloride Tablet Market - Competitive Landscape |
10.1 Japan Exeter Erlotinib Hydrochloride Tablet Market Revenue Share, By Companies, 2024 |
10.2 Japan Exeter Erlotinib Hydrochloride Tablet Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |